General Information of Drug Transporter (DT)
DT ID DTD0420 Transporter Info
Gene Name SLC5A11
Transporter Name Sodium/myo-inositol cotransporter 2
Gene ID
115584
UniProt ID
Q8WWX8
Epigenetic Regulations of This DT (EGR)

Methylation

  Atypical teratoid rhabdoid tumor

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg04022912)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.53E-08; Z-score: -1.51E+00

Methylation in Case

7.93E-01 (Median) Methylation in Control 8.33E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.49E+00 Statistic Test p-value: 5.52E-08; Z-score: 1.14E+00

Methylation in Case

2.52E-01 (Median) Methylation in Control 1.69E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 1.32E-05; Z-score: 6.84E-01

Methylation in Case

2.15E-01 (Median) Methylation in Control 1.89E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg01435766)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 6.59E-05; Z-score: 7.64E-01

Methylation in Case

8.96E-01 (Median) Methylation in Control 8.31E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Bladder cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in bladder cancer [ 2 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.70E+00 Statistic Test p-value: 1.37E-12; Z-score: -2.26E+01

Methylation in Case

2.98E-01 (Median) Methylation in Control 8.03E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in bladder cancer [ 2 ]

Location

5'UTR (cg04022912)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 2.05E-03; Z-score: -5.41E+00

Methylation in Case

5.98E-01 (Median) Methylation in Control 7.05E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in bladder cancer [ 2 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.09E+00 Statistic Test p-value: 6.99E-14; Z-score: -2.28E+01

Methylation in Case

2.30E-01 (Median) Methylation in Control 7.10E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in bladder cancer [ 2 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.24E+00 Statistic Test p-value: 1.94E-10; Z-score: -9.53E+00

Methylation in Case

2.10E-01 (Median) Methylation in Control 4.71E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.50E-10; Z-score: -2.41E+00

Methylation in Case

6.41E-01 (Median) Methylation in Control 7.51E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.35E+00 Statistic Test p-value: 3.78E-05; Z-score: 8.63E-01

Methylation in Case

2.04E-01 (Median) Methylation in Control 1.52E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.39E+00 Statistic Test p-value: 9.99E-21; Z-score: -3.40E+00

Methylation in Case

3.56E-01 (Median) Methylation in Control 4.96E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 3.96E-07; Z-score: -1.36E+00

Methylation in Case

5.47E-01 (Median) Methylation in Control 6.43E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

TSS1500 (cg02428538)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.18E-03; Z-score: -1.05E+00

Methylation in Case

9.10E-01 (Median) Methylation in Control 9.45E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A11 in breast cancer [ 3 ]

Location

Body (cg01435766)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 5.74E-03; Z-score: 2.91E-01

Methylation in Case

6.39E-02 (Median) Methylation in Control 5.61E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in colorectal cancer [ 4 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 9.10E-10; Z-score: -2.34E+00

Methylation in Case

7.43E-01 (Median) Methylation in Control 8.66E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in colorectal cancer [ 4 ]

Location

5'UTR (cg04022912)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 2.49E-02; Z-score: -3.43E-01

Methylation in Case

9.08E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in colorectal cancer [ 4 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 2.54E-07; Z-score: -1.87E+00

Methylation in Case

5.84E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in colorectal cancer [ 4 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 4.65E-04; Z-score: -9.82E-01

Methylation in Case

4.92E-01 (Median) Methylation in Control 5.82E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A11 in colorectal cancer [ 4 ]

Location

Body (cg01435766)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.45E+00 Statistic Test p-value: 2.93E-02; Z-score: -4.81E-01

Methylation in Case

6.80E-02 (Median) Methylation in Control 9.83E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Moderate/moderate hypermethylation of SLC5A11 in colorectal cancer than that in healthy individual/adjacent tissue

Studied Phenotype

Colorectal cancer [ICD-11:2B91]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.008540784; Fold-change: 0.236222994; Z-score: 1.285241014

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 0.022796826; Fold-change: 0.283624798; Z-score: 1.912490742
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals

  Depression

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in depression [ 5 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 3.02E-02; Z-score: 6.09E-01

Methylation in Case

3.68E-01 (Median) Methylation in Control 3.13E-01 (Median)

Studied Phenotype

Depression [ ICD-11: 6A8Z]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.60E-07; Z-score: -1.46E+00

Methylation in Case

7.56E-01 (Median) Methylation in Control 8.04E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 3.12E-03; Z-score: 1.02E+00

Methylation in Case

5.32E-01 (Median) Methylation in Control 4.59E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 1.14E-08; Z-score: -1.76E+00

Methylation in Case

5.52E-01 (Median) Methylation in Control 6.82E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

TSS200 (cg00339695)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 4.44E-05; Z-score: -1.12E+00

Methylation in Case

4.20E-01 (Median) Methylation in Control 5.29E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

Body (cg06593603)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.69E+00 Statistic Test p-value: 5.28E-11; Z-score: -3.03E+00

Methylation in Case

3.25E-01 (Median) Methylation in Control 5.51E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A11 in hepatocellular carcinoma [ 6 ]

Location

Body (cg01435766)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.56E+00 Statistic Test p-value: 3.27E-07; Z-score: 1.74E+00

Methylation in Case

4.72E-01 (Median) Methylation in Control 3.02E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in HIV infection [ 7 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.38E+00 Statistic Test p-value: 1.07E-04; Z-score: 1.21E+00

Methylation in Case

4.32E-01 (Median) Methylation in Control 3.13E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in HIV infection [ 7 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.63E-04; Z-score: -1.18E+00

Methylation in Case

8.03E-01 (Median) Methylation in Control 8.42E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in HIV infection [ 7 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 1.24E-03; Z-score: -1.13E+00

Methylation in Case

6.84E-01 (Median) Methylation in Control 7.51E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in HIV infection [ 7 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 2.99E-02; Z-score: -4.49E-01

Methylation in Case

5.49E-01 (Median) Methylation in Control 5.71E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A11 in HIV infection [ 7 ]

Location

Body (cg01435766)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 1.88E-03; Z-score: 8.92E-01

Methylation in Case

1.01E-01 (Median) Methylation in Control 7.82E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in lung adenocarcinoma [ 8 ]

Location

5'UTR (cg06028605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.37E+00 Statistic Test p-value: 5.10E-04; Z-score: 3.67E+00

Methylation in Case

3.53E-01 (Median) Methylation in Control 2.58E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in lung adenocarcinoma [ 8 ]

Location

TSS200 (cg00339695)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 3.42E-02; Z-score: 1.15E+00

Methylation in Case

7.14E-01 (Median) Methylation in Control 6.44E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in papillary thyroid cancer [ 9 ]

Location

5'UTR (cg26870567)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 5.26E-04; Z-score: -5.02E-01

Methylation in Case

8.84E-01 (Median) Methylation in Control 8.96E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in papillary thyroid cancer [ 9 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.50E+00 Statistic Test p-value: 3.50E-18; Z-score: -3.92E+00

Methylation in Case

4.26E-01 (Median) Methylation in Control 6.38E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in papillary thyroid cancer [ 9 ]

Location

TSS1500 (cg04399565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 3.71E-07; Z-score: -1.56E+00

Methylation in Case

7.02E-01 (Median) Methylation in Control 8.02E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in pancretic ductal adenocarcinoma [ 10 ]

Location

TSS1500 (cg12122597)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.67E+00 Statistic Test p-value: 1.81E-16; Z-score: 2.32E+00

Methylation in Case

3.92E-01 (Median) Methylation in Control 2.36E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in pancretic ductal adenocarcinoma [ 10 ]

Location

Body (cg09951201)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 8.64E-08; Z-score: -1.64E+00

Methylation in Case

6.75E-01 (Median) Methylation in Control 8.12E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A11 in pancretic ductal adenocarcinoma [ 10 ]

Location

Body (cg03711791)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 7.84E-05; Z-score: 1.05E+00

Methylation in Case

7.72E-01 (Median) Methylation in Control 7.14E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A11 in pancretic ductal adenocarcinoma [ 10 ]

Location

3'UTR (cg12504828)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.04E-03; Z-score: 4.97E-01

Methylation in Case

7.29E-01 (Median) Methylation in Control 7.05E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A11 in pancretic ductal adenocarcinoma [ 10 ]

Location

3'UTR (cg06912964)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 3.82E-02; Z-score: 3.71E-01

Methylation in Case

7.41E-01 (Median) Methylation in Control 7.24E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Prostate cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in prostate cancer [ 11 ]

Location

TSS1500 (cg26735834)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 3.68E-03; Z-score: 4.43E+00

Methylation in Case

9.05E-01 (Median) Methylation in Control 7.03E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A11 in prostate cancer [ 11 ]

Location

Body (cg00691874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 2.45E-02; Z-score: 2.98E+00

Methylation in Case

7.73E-01 (Median) Methylation in Control 6.33E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A11 in systemic lupus erythematosus [ 12 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 9.46E-03; Z-score: -2.92E-01

Methylation in Case

6.11E-01 (Median) Methylation in Control 6.40E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Myxopapillary ependymoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A11 in myxopapillary ependymoma than that in healthy individual

Studied Phenotype

Myxopapillary ependymoma [ICD-11:2A00.5]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.005338976; Fold-change: 0.209210184; Z-score: 1.181585542
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Oligodendroglial tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A11 in oligodendroglial tumour than that in healthy individual

Studied Phenotype

Oligodendroglial tumour [ICD-11:2A00.Y1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 7.02E-05; Fold-change: 0.210630745; Z-score: 4.191537336
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Spinal ependymoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A11 in spinal ependymoma than that in healthy individual

Studied Phenotype

Spinal ependymoma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.02E-07; Fold-change: 0.225515591; Z-score: 1.208291051
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Brain neuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A11 in brain neuroblastoma than that in healthy individual

Studied Phenotype

Brain neuroblastoma [ICD-11:2A00.11]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 2.88E-09; Fold-change: -0.269367273; Z-score: -1.664765767
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Uterine carcinosarcoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A11 in uterine carcinosarcoma than that in healthy individual

Studied Phenotype

Uterine carcinosarcoma [ICD-11:2B5F]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.75E-05; Fold-change: -0.298966361; Z-score: -2.197751588
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC5A11 in melanoma than that in healthy individual

Studied Phenotype

Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.000768166; Fold-change: -0.303836643; Z-score: -2.0125068
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC5A11 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 7.86E-11; Fold-change: -0.309568774; Z-score: -2.012368811
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A11 in liver cancer than that in adjacent tissue

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 3.60E-08; Fold-change: -0.215954581; Z-score: -1.914767677
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
References
1 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 DNA methylation and inflammation marker profiles associated with a history of depression. Hum Mol Genet. 2018 Aug 15;27(16):2840-2850.
6 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
7 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
8 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
9 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
10 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
11 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
12 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.